Stock chartWhen you look at a weekly chart of SVA like the one below, you can see that we have been in a fairly narrow trading range (ignoring the odd anomaly) since about March of 2021. That compares pretty favourably with the S&P Biotechnology Index one year return of -45.98% and the Nasdaq Biotechnology Index one year return of -22.15%. Often, the longer a stock trades sideways, the greater the breakout if and when it happens. I think we have a lot of strong retail hands waiting on developments. Hopefully, with our new partner and the uplist to the TSX, we will get some strong institutional money. Then we just need the sector to turn back green and Bob's your uncle.